Related Experiment Video
Updated: Jun 5, 2025
07:27
Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
Published on: February 7, 2025
418
Robotic-assisted partial nephrectomy using the HugoTM robotic-assisted surgery platform Initial experience and
Adam Bobrowski1, William Wu2, Chelsea Angeles2,3
1Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Summary
This study shows the Hugo™ RAS system is safe and effective for robotic-assisted partial nephrectomy (RAPNx). Early outcomes in North America demonstrate comparable results to existing robotic platforms.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Robotic-assisted surgery (RAS) is crucial for minimally invasive procedures.
- The Hugo™ RAS system is a new platform with limited outcome data.
- This study evaluates early outcomes of the Hugo™ RAS system for partial nephrectomy.
Purpose of the Study:
- To assess the safety and efficacy of the Hugo™ RAS system for robotic-assisted partial nephrectomy (RAPNx).
- To report initial surgical outcomes from a North American case series.
Main Methods:
- Retrospective review of 11 patients undergoing RAPNx with the Hugo™ RAS system.
- Procedures performed by a single surgeon using a transperitoneal approach.
- Data collected from anesthetic, operative, and pathology reports.
Main Results:
- Mean patient age 51 years, 45% female, 63.6% right-sided tumors.
- Mean tumor size 2.9 cm; mean warm ischemia time 18.9 minutes.
- No intraoperative complications; all margins negative; one port site infection.
Conclusions:
- The Hugo™ RAS platform is safe and effective for RAPNx.
- Early outcomes are comparable to other established robotic platforms.
- This represents the first North American case series for RAPNx using the Hugo™ system.
